Zhao Bixing相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications

更正：阿伐普利尼靶向抑制PDGFRA可显著增强乐伐替尼在体外和体内治疗肝细胞癌的疗效：临床意义

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-025-03423-6

Zhao, Bixing; Zhou, Yang; Cheng, Niangmei; Zheng, Xiaoyuan; Chen, Geng; Qi, Xin; Zhang, Xiangzhi; Wang, Fei; Zhuang, Qiuyu; Assaraf, Yehuda G; Liu, Xiaolong; Wang, Yingchao; Zeng, Yongyi

细胞生物学

发表日期：2025

文献求助收藏

Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.

用阿伐替尼靶向抑制 PDGFRA，可显著增强乐伐替尼在体外和体内治疗肝细胞癌的疗效：临床意义

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-025-03386-8

Zhao Bixing, Zhou Yang, Cheng Niangmei, Zheng Xiaoyuan, Chen Geng, Qi Xin, Zhang Xiangzhi, Wang Fei, Zhuang Qiuyu, Assaraf Yehuda G, Liu Xiaolong, Wang Yingchao, Zeng Yongyi

细胞生物学

发表日期：2025

文献求助收藏

Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET

缺氧诱导的外泌体LUCAT1通过稳定c-MET促进肺腺癌细胞对奥希替尼的耐药性。

期刊:Cell Death & Disease

影响因子:9.6

doi:10.1038/s41419-025-08100-2

Du, Jianting; Zheng, Bin; Qian, Jiekun; Huang, Guanglei; Yuan, Wenjie; Huang, Renjie; Gong, Xian; Xu, Guobing; Zhao, Bixing; Liu, Xiaolong; Wang, Yingchao; Yang, Zhang; Chen, Chun

细胞生物学

发表日期：2025

文献求助收藏

Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression.

利用人工环状RNA作为miRNA海绵和抗PD-1 scFv表达平台来抑制肝细胞癌的进展

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1609165

Lai Yongping, Wang Fei, Cai Guang, Li Yingying, Weng Jiaxin, Cai Feifan, Cai Leijie, Cheng Niangmei, Zhao Bixing, Zeng Yongyi

细胞生物学

发表日期：2025

文献求助收藏

Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway

还原型谷胱甘肽通过靶向TGFβ1/SMAD3/NOX4通路增强脂肪组织来源间充质干细胞在肝纤维化中的移植效率。

期刊:Bioengineering & Translational Medicine

影响因子:5.7

doi:10.1002/btm2.10735

Yu, Shaoxiong; Wang, Yingchao; Shi, Yingjun; Yu, Saihua; Zhao, Bixing; Liao, Naishun; Liu, Xiaolong

发育与干细胞

细胞生物学

发表日期：2025

文献求助收藏

DGKH-PA-mTOR: A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma

DGKH-PA-mTOR：肝细胞癌中酪氨酸激酶抑制剂耐药性的药理学靶向代谢轴

doi:10.1016/j.iliver.2025.100198

Cai, Feifan; Zhao, Bixing

细胞生物学

发表日期：2025

文献求助收藏

Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy

用于肝细胞癌免疫治疗的基于环状RNA的新抗原疫苗

影响因子:10.7

doi:10.1002/mco2.667

Wang, Fei; Cai, Guang; Wang, Yingchao; Zhuang, Qiuyu; Cai, Zhixiong; Li, Yingying; Gao, Shaodong; Li, Fang; Zhang, Cuilin; Zhao, Bixing; Liu, Xiaolong

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

ADAR1-Mediated RNA Editing and Its Role in Cancer

ADAR1介导的RNA编辑及其在癌症中的作用

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2022.956649

Liu, Jizhe; Wang, Fei; Zhang, Yindan; Liu, Jingfeng; Zhao, Bixing

发表日期：2022

文献求助收藏

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma

建立预后评估模型以预测肝细胞癌患者的总生存期和早期复发

期刊:Journal of Hepatocellular Carcinoma

影响因子:3.4

doi:10.2147/JHC.S303330

Zhong, Yue; Yang, Yong; He, Lei; Zhou, Yang; Cheng, Niangmei; Chen, Geng; Zhao, Bixing; Wang, Yingchao; Wang, Gaoxiong; Liu, Xiaolong

细胞生物学

发表日期：2021

文献求助收藏

Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model

在小鼠肝纤维化模型中，抗氧化剂预处理可通过提高肝内移植效率来改善脂肪组织来源间充质干细胞的治疗效果。

期刊:Stem Cell Research & Therapy

影响因子:7.3

doi:10.1186/s13287-020-01763-y

Liao, Naishun; Shi, Yingjun; Wang, Yingchao; Liao, Fangyu; Zhao, Bixing; Zheng, Youshi; Zeng, Yongyi; Liu, Xiaolong; Liu, Jingfeng

细胞生物学

发育与干细胞

发表日期：2020

文献求助收藏